FDA Finds Statins Not Linked To ALS; When Can A False Alarm Be Turned Off?

FDA's determination that statins do not increase the incidence of amyotrophic lateral sclerosis suggests that agency will continue to rely on data from placebo controlled trials to address concerns raised in post-marketing reports